The Artificial Intelligence in Drug Repurposing market size is expected to reach $2.63 billion in 2030 at 20.1%, driven by rising demand for precision medicine.
The AI in life science analytics market is projected to reach $6.16B by 2030, growing at 18.4% CAGR, driven by precision diagnostics, AI drug development, cloud analytics, and real-world evidence insights.
The AI in genomics market is projected to reach $9.32B by 2030, growing at 43.7% CAGR, driven by precision medicine, AI drug discovery, population genomics, and advanced genomic analytics.
Global Artificial Intelligence in Diabetes Management market size is expected to reach $3.4 billion by 2030 at 33.7%, ai revolution is transforming diabetes management in response to soaring prevalence
Test Message
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.